Depomed Inc. (DEPO)

7.18
0.06 0.84
NASDAQ : Health Technology
Prev Close 7.12
Open 7.06
Day Low/High 6.98 / 7.28
52 Wk Low/High 4.31 / 11.27
Volume 334.94K
Avg Volume 1.24M
Exchange NASDAQ
Shares Outstanding 63.59M
Market Cap 443.20M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of DEPO December 21st Options Trading

Investors in Depomed Inc saw new options begin trading this week, for the December 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Depomed Announces The Appointment Of Stan Bukofzer, M.D. As Senior Vice President And Chief Medical And Scientific Officer

Depomed Announces The Appointment Of Stan Bukofzer, M.D. As Senior Vice President And Chief Medical And Scientific Officer

Global Business Executive Brings Over 20 Years of Medical and Scientific Leadership Experience

First Week Of DEPO May 18th Options Trading

First Week Of DEPO May 18th Options Trading

Investors in Depomed Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Depomed Announces New Corporate Headquarters

Depomed Announces New Corporate Headquarters

- Relocating Headquarters to Landmark Conway Farms Office Park in Lake Forest, Illinois -

DEPO Makes Bullish Cross Above Critical Moving Average

DEPO Makes Bullish Cross Above Critical Moving Average

In trading on Tuesday, shares of Depomed Inc crossed above their 200 day moving average of $7.85, changing hands as high as $7.96 per share. Depomed Inc shares are currently trading up about 1.8% on the day.

First Week of April 20th Options Trading For Depomed (DEPO)

First Week of April 20th Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options begin trading this week, for the April 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DEPO options chain for the new April 20th contracts and identified one put and one call contract of particular interest.

Opioid Litigants Get Boost From Senate Report

Opioid Litigants Get Boost From Senate Report

A report released by Missouri Sen. Claire McCaskill points to $10 million of payments flowing from a group of five opioid-producing companies to 15 patient advocacy groups over a five-year period.

Depomed is Now Oversold (DEPO)

Depomed is Now Oversold (DEPO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Depomed Breaks Above 200-Day Moving Average - Bullish for DEPO

Depomed Breaks Above 200-Day Moving Average - Bullish for DEPO

In trading on Thursday, shares of Depomed Inc crossed above their 200 day moving average of $8.57, changing hands as high as $8.58 per share. Depomed Inc shares are currently trading up about 2.8% on the day.

Depomed Announces Closing Of NUCYNTA Commercialization Agreement With Collegium Pharmaceutical

Depomed Announces Closing Of NUCYNTA Commercialization Agreement With Collegium Pharmaceutical

Closing Triggers Upfront $10 Million Payment to Depomed

Depomed Reaches Analyst Target Price

Depomed Reaches Analyst Target Price

In recent trading, shares of Depomed Inc have crossed above the average analyst 12-month target price of $8.14, changing hands for $8.53/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Skyworks Solutions Is 1 of 5 Big Stocks Ready to Abruptly Change Direction

Skyworks Solutions Is 1 of 5 Big Stocks Ready to Abruptly Change Direction

These names are showing bullish or bearish reversal patterns that occurred over the past week.

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

TheStreet recounts the successes and failures of the biggest names in the activism game.

First Week of June 2018 Options Trading For Depomed (DEPO)

First Week of June 2018 Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options begin trading this week, for the June 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Depomed Announces Appointment Of Santosh J. Vetticaden, M.D., PH.D. As Senior Vice President, Chief Medical And Scientific Officer

Depomed Announces Appointment Of Santosh J. Vetticaden, M.D., PH.D. As Senior Vice President, Chief Medical And Scientific Officer

25 Year Pharmaceutical and Biotechnology Industry Executive Joins Senior Management Team

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Depomed, Inc. (DEPO)

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Depomed, Inc. (DEPO)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the October 17, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Depomed, Inc.

Relative Strength Alert For Depomed

Relative Strength Alert For Depomed

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 17th Lead Plaintiff Deadline In Securities Class Action Against Depomed, Inc. (DEPO)

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 17th Lead Plaintiff Deadline In Securities Class Action Against Depomed, Inc. (DEPO)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that October 17, 2017, is the deadline to move for lead plaintiff status in the...

TheStreet Quant Rating: D (Sell)